O-161 Efficacy of antibacterial prophylaxis following myelosuppressive chemotherapy: Results from a randomised, double-blind, placebo-controlled trial of levofloxacin including 220 small cell lung cancer patients

Lung Cancer ◽

10.1016/s0169-5002(05)80295-8 ◽

2005 ◽

Vol 49 ◽

pp. S55

Author(s):

L. Billingham ◽

M. Cullen ◽

N. Steven ◽

C. Gaunt ◽

M. Hastings

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Controlled Trial ◽

Small Cell ◽

Antibacterial Prophylaxis ◽

Small Cell Lung ◽

Double Blind ◽

Myelosuppressive Chemotherapy ◽

Double Blind Placebo ◽

Lung Cancer Patients

Download Full-text

Reply to “Letter to the Editor on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study’”, by V. C. G. Tjan-Heijnen, P. E. Postmus &A. Ardizzoni(Ann Oncol 2002; 13: 485–486)

Annals of Oncology ◽

10.1093/annonc/mdf139 ◽

2002 ◽

Vol 13 (3) ◽

pp. 486 ◽

Cited By ~ 1

Author(s):

P. Bunn

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

Prophylactic Use

Download Full-text

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study

Annals of Oncology ◽

10.1023/a:1012545507920 ◽

2001 ◽

Vol 12 (10) ◽

pp. 1359-1368 ◽

Cited By ~ 80

Author(s):

V.C.G. Tjan-Heijnen ◽

P.E. Postmus ◽

A. Ardizzoni ◽

Ch. Manegold ◽

J. Burghouts ◽

...

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

Prophylactic Use

Download Full-text

Economic evaluation of antibiotic prophylaxis in small-cell lung cancer patients receiving chemotherapy: an EORTC double-blind placebo-controlled phase III study (08923)

Annals of Oncology ◽

10.1093/annonc/mdg073 ◽

2003 ◽

Vol 14 (2) ◽

pp. 248-257 ◽

Cited By ~ 19

Author(s):

V.C.G. Tjan-Heijnen ◽

S. Caleo ◽

P.E. Postmus ◽

A. Ardizzoni ◽

J.T.M. Burghouts ◽

...

Keyword(s):

Lung Cancer ◽

Economic Evaluation ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

Editorial comments on ‘Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: An EORTC double-blind placebo-controlled phase III study’

Annals of Oncology ◽

10.1023/a:1012579018035 ◽

2001 ◽

Vol 12 (10) ◽

pp. 1339-1340 ◽

Cited By ~ 5

Author(s):

P.A. Bunn

Keyword(s):

Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study ◽

Prophylactic Use

Download Full-text

A multicenter, randomized, double-blind, placebo-controlled phase III study of monosialoganglioside (GM1) preventing neurotoxicity induced by cisplatin-based chemotherapy in non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.tps10142 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. TPS10142-TPS10142

Author(s):

Li Zhang ◽

Ting Zhou ◽

Yuxiang Ma ◽

Yunpeng Yang ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Lung Cancer Patients ◽

Phase Iii Study

Download Full-text

1787P Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1548 ◽

2020 ◽

Vol 31 ◽

pp. S1036

Author(s):

Y. Liu ◽

Y. Cheng ◽

Q. Wang ◽

K. Li ◽

J. Shi ◽

...

Keyword(s):

Lung Cancer ◽

Pleural Effusion ◽

Cancer Patients ◽

Subgroup Analysis ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Lung Cancer Patients ◽

Pleural Metastases

Download Full-text

A phase II/III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced Non-Small Cell Lung Cancer (NSCLC)

http://isrctn.org/> ◽

10.1186/isrctn77341241 ◽

2012 ◽

Author(s):

Siow Ming Lee

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)

Lung Cancer ◽

10.1016/j.lungcan.2009.06.020 ◽

2010 ◽

Vol 68 (2) ◽

pp. 234-239 ◽

Cited By ~ 83

Author(s):

Aminah Jatoi ◽

Howard L. Ritter ◽

Amylou Dueck ◽

Phuong L. Nguyen ◽

Daniel A. Nikcevich ◽

...

Keyword(s):

Lung Cancer ◽

Weight Loss ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Poor Performance ◽

Small Cell ◽

Double Blind Trial ◽

Small Cell Lung ◽

Double Blind ◽

Lung Cancer Patients

Download Full-text

ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7631 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7631-7631 ◽

Cited By ~ 11

Author(s):

M. Schuster ◽

J. R. Rigas ◽

S. V. Orlov ◽

B. Milovanovic ◽

K. Prabhash ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

NCIC CTG BR.26: A phase III randomized, double blind, placebo controlled trial of dacomitinib versus placebo in patients with advanced/metastatic non-small cell lung cancer (NSCLC) who received prior chemotherapy and an EGFR TKI.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8036 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8036-8036 ◽

Cited By ~ 6

Author(s):

Peter Michael Ellis ◽

Geoffrey Liu ◽

Michael Millward ◽

Francesco Perrone ◽

Frances A. Shepherd ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Controlled Trial ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Prior Chemotherapy ◽

Egfr Tki

Download Full-text